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The plasma membrane of nearly all mammalian cells bears a glycocalyx layer, consisting of glycolipids, glycoproteins and proteoglycans, whose carbohydrate structures have been well defined in cells at various stages of proliferation and differentiation to determine the histoblood group antigenicity and several carbohydrate-mediated functions. 1) During the transformation of cells, alterations in the cell surface carbohydrates have been frequently observed, mainly due to the aberrant expression of glycosyl transferases, and among the transformation-associated carbohydrates, CA19-9, with a sialylated lacto-N-fucopentaose (sialyl Le a ) structure, has been successfully applied for the clinical diagnosis of cancer patients. 2, 3) In addition, on the basis of the finding that sialylated or sulfated Lewis carbohydrates are involved in the ligands for selectins, 4, 5) cancer cells expressing sialylated or sulfated Lewis structures have been shown to exhibit high dissemination and metastatic potentials through selectins, and the concentrations of these molecules in cancer cells and tissues, and in sera of patients have provided useful clues for predicting metastasis. 6, 7) Also, the expression of Le b , Le Y , H and mucin core antigen-1 has been reported to be related to the grade of dysplasia and malignancy in cancer patients, and can be used to predict prognosis. 8, 9) However, such carbohydrate structures applicable to clinical diagnosis are synthesized through multi-step reactions by several glycosyltransferases, the activities of which are influenced by availability of the respective sugar nucleotides, acceptor carbohydrate chains, and other factors including divalent cations, indicating that tumor-associated carbohydrates are dependent upon various epigenetic factors. To understand the metabolic alterations causing the expression of histo-blood group antigens in cancer cells, quantitative determination of all molecular species of carbohydrates including metabolic precursors is necessary. For this purpose, analysis of the glycosphingolipid (GSL) composition should provide useful information because GSLs with carbohydrate moieties of different chain lengths can be readily separated by means of a convenient procedure. In our previous study, human uterine 5 To whom correspondence and reprint requests should be addressed.
E-mail: iwamori@chem.kindai.ac.jp endometrial carcinoma-derived cells were shown to express high specific activity of β1,3-galactosyltransferase for the synthesis of lacto-N-tetraosyl ceramide as an important precursor of Lewis-GSL. 10) We have now extended this study to determine the entire GSL compositions in various gynecological cancer-derived cells and to compare the expression of Lewis-GSLs in tissues from patients with various grades of endometrial carcinomas.
MATERIALS AND METHODS

Materials
Glycolipids were purified from various sources in our laboratory: I 3 SO 3 -GalCer, GM2, GD3, GM1 and GD1a from bovine brain, GlcCer, LacCer, Gb 3 Cer, Gb 4 Cer, GM3 and IV 3 NeuAc-nLc 4 Cer from human erythrocytes, Lc 4 4 Cer were prepared by treatment with Arthrobacter ureafaciens sialidase as reported previously, 11) and N-stearoyl derivatives of GlcCer, LacCer and Gb 3 Cer were synthesized by acylation of glucosyl, lactosyl and globotetraosyl sphingosine, prepared with sphingolipid ceramide N-descylase (Pseudomonas sp. TK4), 12) with stearoyl chloride.
13)
Carbohydrate-specific antibodies
Rabbit polyclonal antibodies toward GM1, asialo GM1 and asialo GM2 were generated by immunizing rabbits intradermally with an emulsion prepared with 1 mg of purified glycolipid and 0.5 mg of BSA (bovine serum albumin) in 1 ml of PBS (phosphate-buffered saline), and 1 ml of Freund's complete adjuvant (Sigma, St. Louis, MO), and by monitoring the antibody titer by means of an enzyme-linked immunosorbent assay, the titers being 1:100 000 for anti-GM1, 1:600 000 for anti-asialo GM1, and 1:300 000 for antiasialo GM2 antibodies. No cross reaction with structurally related glycolipid derivatives of individual antigens was observed. 14) Human monoclonal anti-Lc 4 Cer (HMST-1), 15) mouse monoclonal anti-Le b plus Le Y (MSN-1), 16) and anti-GM2 (YHD-06) 17) antibodies were established in our laboratory. [18] [19] [20] [21] [22] [23] [24] [25] Human tissues Cancerous tissues from patients suffering from uterine endometrial adenocarcinomas and normal endometria were obtained from the Departments of Pathology, and Obstetrics and Gynecology, Keio University Hospital, and National Saitama Hospital after pathological examination, and were used according to the guidelines of the Committee for Informed Consent. Separation and quantitation of GSLs The cultured cells were harvested with a scraper and then lyophilized. Total lipids were extracted from the lyophilized cells with chloroform/methanol/water (20:10:1, 10:20:1 and 1:1, by vol.), and then the combined extracts were fractionated into neutral and acidic lipids on a DEAE-Sephadex column (A-25, acetate form; Pharmacia, Uppsala, Sweden). The neutral GSLs were separated from unabsorbed neutral lipid fractions by acetylation, separation of the acetylated GSLs, deacetylation and desalting, whereas the acidic GSLs were prepared from the absorbed acidic lipid fractions by cleavage of the ester-containing lipids, followed by dialysis.
26) The acidic and neutral GSLs thus obtained were developed on TLC (thin-layer chromatography) plates with chloroform/methanol/0.5% CaCl 2 in water (55:45:10, by vol.) and chloroform/methanol/water (65:35:8, by vol.), respectively, and then visualized with orcinol-H 2 SO 4 reagent. The density of spots was determined at an analytical wavelength of 420 nm and a control wavelength of 710 nm using a dual-wavelength TLC densitometer (CS-9000; Shimadzu, Kyoto). Standard curves were essentially obtained by using the same GSLs as those detected in the cells: 0.1 to 1.5 µg of GalCer (18: NeuAc-nLc 4 Cer, GM2, GD3, GM1 and GD1a, on the same plate. The concentration of lipid-bound sialic acid was also determined densitometrically after visualization of the spots with resorcinol-HCl reagent, and the density of the spots was determined at an analytical wavelength of 580 nm and a control wavelength of 710 nm. TLC-immunostaining The neutral and acidic GSLs prepared from cultured cells and total lipid extracts from the cancerous tissues were applied on plastic-coated TLC plates, which were then developed successively with nhexane/diethyl ether (4:1, by vol.) and chloroform/ methanol/0.5% CaCl 2 in water (55:45:10, by vol.). Each plate was incubated with a blocking buffer (1% PVP (polyvinylpyrrolidone) and 1% ovalbumin in PBS) at 4°C overnight and then with anti-carbohydrate antibodies in 3% PVP in PBS at 37°C for 2 h. Mouse monoclonal antibodies were used at the concentration of approximately 0.2 µg/ml, and rabbit antisera were usually diluted to 1: 500 (by vol.). Afterward, the plates were washed 5 times with 0.1% Tween 20 in PBS, and the bound antibodies were detected using peroxidase-conjugated anti-rabbit IgG+M or anti-mouse IgG+M antibodies (Cappel Laboratories, Cochranville, PA), diluted 1:1000 (by vol.) with 3% PVP in PBS, and with enzyme substrates H 2 O 2 and 4-chloro-1-naphthol, as described previously.
27) The density of spots was also determined using 10 to 100 ng of the respective GSLs as standards for quantitation with a TLCdensitometer as described above, and the limit of detection was 5 ng of GSLs. Structural analysis and quantitation of GSLs The individual GSLs were purified using a silica gel (Iatrobeads 6RS8060; Iatron Lab., Tokyo) column, with gradient elution with chloroform/isopropyl alcohol/water (85:15:0.2 and 40:60:2, by vol.) for mono-to trihexaosyl ceramides in the neutral GSLs and for sulfatides in the acidic GSLs, followed by a gradient of chloroform/methanol/water (70:30:4 and 10:90:4, by vol.) for polar GSLs. Then, characterization and quantitation of individual GSLs were performed as follows. Ceramide monohexosides: Purified ceramide monohexosides were chromatographed on a borate-impregnated plate with chloroform-methanol-water-15 M ammonia (280:70:6:1, by vol.) to separate and quantitate GlcCer and GalCer. Ceramide trihexosides: Gb 3 Cer closely migrated with Lc 3 Cer, but was separated from Gg 3 Cer on a silica gel column, and after quantitation of Gb 3 Cer plus Lc 3 Cer by TLC-densitometry, Lc 3 Cer was removed by enzymatic hydrolysis with N-acetyl β-glucosamidase (bovine kidney; Sigma), followed by determination of the product, LacCer from Lc 3 Cer, and the remaining Gb 3 Cer as above. Gg 3 Cer was determined by TLC-immunostaining with anti-Gg 3 Cer antibodies. Ceramide tetrahexosides: By silica gel column chromatography, Gb 4 Cer was separated from the mixture of Lc 4 Cer and nLc 4 Cer, in which the concentration of Lc 4 Cer was determined by TLC-immunostaining with anti-Lc 4 Cer antibodies, and the amount of nLc 4 Cer was calculated by subtraction of the amount of Lc 4 Cer from that of the mixture. On the other hand, Gg 4 Cer migrated in the region of ceramide pentahexosides and was quantitated by TLCimmunostaining with anti-Gg 4 3 Cer were characterized by negative ion FABMS (JMS-700TKM; JEOL Ltd., Tokyo) with triethanolamine as a matrix solvent, 28) and their amounts were determined by TLC-densitometry as described above. IV 3 NeuAc-Lc 4 Cer, IV 3 NeuAc-nLc 4 Cer and GM2: These GSLs migrated together on a TLC plate, as well as on a silica gel column, and therefore after isolation of the band containing these GSLs, sialidase (Vibrio cholerae; Calbiochem, San Diego, CA) treatment, which was able to remove sialic acid from IV NeuAcnLc 4 Cer, but not from GM2, was performed to separate Lc 4 Cer plus nLc 4 Cer from GM2 by TLC. Then their amounts were determined by TLC-densitometry and TLCimmunostaining with known amounts of nLc 4 Cer and GM2, respectively, followed by determination of Lc 4 Cer in the Lc 4 Cer plus nLc 4 Cer-band by TLC-immunostaining with anti-Lc 4 Cer antibodies. Gangliosides: GM3 and GD3 were characterized by comparison of their mobilities on a TLC plate with those of standard GSLs before and after sialidase treatment. In a similar way, GM1 and GD1a were characterized by TLC-immunostaining with anti-GM1 antibodies before and after sialidase (V. cholerae) treatment. Thereafter, quantitation of gangliosides was carried out by TLC-densitometry with known amounts of individual GSL as standards.
RESULTS
GSLs in human gynecological cancer-derived cell lines
To determine the precise concentrations of GSLs in the cultured cells, standard curves for quantitation by TLCdensitometry and TLC-immunostaining were prepared using the same purified GSLs as those detected in the cell lines, as described under "Materials and Methods." The results are compiled in Table I . Cholesterol was present in various cell lines at concentrations of 36.7 µg (64.8 nmol) to 41.0 µg (105.9 nmol) per mg of dry weight, and total GSLs amounted to 3 to 4 µg in eight out of 14 cell lines, corresponding to approximately 4 mol% of GSLs with respect to cholesterol. Fig. 1 shows TLC chromatograms of neutral and acidic GSLs in 0.5 mg of dried cells. On chromatograms, at least 10 neutral and 7 acidic GSLs, which were separated according to the differences in the carbohydrate moieties, were detected, but the relative amounts of individual GSLs were distinct among the cells. In no case was an identical GSL composition found in two lines. The ubiquitous GSLs present at concentrations of more than 0.02 µg per mg of dry weight were GlcCer, LacCer, Gb 3 Cer, Lc 3 Cer, Gb 4 Cer and GM3, indicating that the metabolic pathways leading to Gb 4 Cer and GM3 are always active in cell lines established from various human gynecological cancers.
GSLs with trihexose or shorter carbohydrate chains
GlcCer was the major ceramide monohexoside and was maintained at a higher concentration than that of LacCer in all cells, probably due to the kinetic properties of β-galactosyl transferase as to the synthesis of LacCer. The subsequent metabolic steps from LacCer, involving sialyl, sulfo, α-galactosyl, β-N-acetylglucosaminyl and β-Nacetylgalactosaminyl transferases to afford GM3, II 3 SO 3 -LacCer, Gb 3 Cer, Lc 3 Cer and Gg 3 Cer, respectively, determine the extension of the carbohydrate chains. Among them, Gb 3 Cer, Lc 3 Cer and GM3 were ubiquitous at concentrations of more than 0.02 µg per mg of dry weight, providing a sufficient supply of precursors for the globo-, lacto-and ganglio-series GSL pathways (Fig. 2) . The ratios of GM3 to LacCer, indicating a gradient of GM3 synthetic potential with appropriate synthetic activity of LacCer as a substrate and consumption of GM3 for the following ganglio-series GSLs in ovarian carcinomaderived cells (6 out of 7 cell lines), were less than 1.0, but the endometrial and cervical carcinoma-derived cells exhibited ratios of higher than 1.0. The ability to sulfate LacCer for the synthesis of II 3 SO 3 -LacCer was observed in 3 endometrial carcinoma-derived cell lines and one ovarian carcinoma-derived cell line. Although the amount of II 3 SO 3 -LacCer was lower than that of LacCer in ovarian carcinoma-derived HAC-2 cells, the ratios of II 3 SO 3 -LacCer to LacCer were 2-to 7-fold in 3 endometrial-derived cell lines, all of which exhibited further synthesis of II 3 SO 3 -Gg 3 Cer by GalNAc transferase (Fig. 1) . Among the neutral trihexaosyl ceramides, Gb 3 Cer and Lc 3 Cer were present at concentrations of 0.02 to 5.77 µg in all cells, and the former was always at a higher concentration than the latter. Gg 3 Cer was only detected in 3 ovarian carcinoma-derived cell lines.
GSLs with tetrahexose or longer carbohydrate chains
In all cells, Gb 4 Cer was present at concentrations of more than 0.06 µg per mg of dry weight, and extended structures of Gb 4 Cer, such as N-acetylhexosamine-Gb 4 Cer, hexose-Gb 4 Cer and NeuAc-hexose-Gb 4 Cer, were not detected at all on negative ion fast atom bombardment mass spectromentry (FABMS), indicating that Gb 4 Cer is the terminal structure of the globo-series GSLs. However, the concentrations of Gb 4 Cer, as well as the ratio of Gb 4 Cer to Gb 3 Cer, were different among the cells, probably due to the activity of Gb 3 Cer:GalNAc-transferase, and were not correlated with the type of cancer. In contrast to the globoseries GSLs, further modification by fucosyl and sialyl transferases of Lc 4 Cer and nLc 4 Cer occurred in all the cell lines except SKG-II, in which nLc 4 Cer was present as the terminal structure of the lacto-series GSLs at significantly high concentrations, and accordingly the concentrations of Lc 4 Cer and nLc 4 Cer in the other cells were less than onetenth of that in SKG-II. Coincident with the previous finding that β1,3-Gal transferase involved in the synthesis of Lc 4 Cer was frequently activated in endometrial carcinoma-derived cells, 10) SNG-II, SNG-M, HEC-108 and Ishikawa cells expressed Lc 4 Cer and its sialylated derivatives (Fig. 3) . Although IV 3 NeuAc-Lc 4 Cer was detected in 5 cell lines, IV 3 NeuAc-nLc 4 Cer was detected in 13 cell lines other than SKG-II. Also, the rate of sialylation of nLc 4 Cer was higher than that of Lc 4 Cer, when the ratios of sialylated derivatives to Lc 4 Cer and nLc 4 Cer were compared. On the other hand, expression of the ganglio-series GSLs, Gg 4 Cer, GM1 and GD1a, was rare in human gynecological cancer-derived cells. Expression of Lewis-phenotypes in human gynecological cancer-derived cells As shown in Fig. 1 and Table I , GSLs with longer carbohydrate chains, which were present at concentrations of more than 0.02 µg per mg of dry weight, comprised lacto-series GSLs, which were modified with fucose to confer the Lewis-phenotypes. Since the synthetic potential for Lc 4 Cer was highly enhanced in the endometrial carcinoma-derived cells, as described above, Lc 4 Cer-based Le a or Le b was detected in 4 Cer were detected by monoclonal antibody MSN-1. On the other hand, the Lewis-phenotypes in cervical and ovarian carcinoma-derived cells were mainly on nLc 4 Cer. In the case of SKG-II cells, Lewis-GSLs were scarcely detected, but a compensatory increase in nLc 4 Cer was observed, probably due to the decreased activities of α1,3-fucosyltransferase, for Le X , and α2,3-sialyltransferase, for IV 3 NeuAc-nLc 4 Cer. Thus, expression of Lewis-phenotypes largely depended on the synthesis of either Lc 4 Cer or nLc 4 Cer. In summary, III Fig. 4 , and antigens were found to be detected sufficiently with 0.2 mg dry weight. Antigens were present in normal endometria at the follicular and luteal phases and in the well-and moderately differentiated types of endometrial carcinoma, but not in the poorly differentiated type (Table II) . The amounts of Le b and Le Y in the well-differentiated type (0.01-0.04 µg/mg of dry weight) were higher than those in the moderately differentiated type (0.01-0.02 µg/mg of dry weight) and normal endometria (less than 0.01 µg/mg of dry weight). Also, the frequency of antigen expression in the well-and moderately differentiated types of endometrial adenocarcinoma was higher than that in the normal endometria tested.
DISCUSSION
Transformation-associated carbohydrate antigens provide a useful means of diagnosis and prediction of the prognosis for patients suffering from cancers. However, their expression on cancerous cells and tissues is not always observed, and their intensity, as detected with specific monoclonal antibodies, is variable in the tissues of individual patients with the same type of cancer and in cell lines during the subculture process. 29) These phenomena are thought to be mainly due to the multi-step metabolism required for the synthesis of carbohydrate antigens, which are composed of plural carbohydrates in both lipid-and protein-conjugated forms. In fact, although all cell lines used in this experiment contained globo-series GSLs up to Gb 4 Cer, the relative concentrations of GlcCer, LacCer, Gb 3 Cer and Gb 4 Cer were entirely different among the cell lines, indicating that the metabolic flow determining the expression of GSL-bearing epitopes is flexibly regulated Table I . Six cell lines exhibited values higher than 1.00, and the other 8 cell lines gave values lower than 1.00, probably due to not only differences in the expression of the GalNAc transferase gene and its enzymatic activity, but also the metabolic equilibrium throughout the synthetic pathways for the globo-and all other series GSLs, because LacCer is also utilized as a common precursor for lacto-and ganglio-series GSLs. In the case of the lacto-series GSLs, Lc 4 Cer and nLc 4 Cer were further converted to sialylated and fucosylated derivatives, and accordingly the concentrations of GSLs in the metabolic route seem to be regulated in complex ways. Actually, the amounts of GSLs belonging to the lacto-series were clearly different among the cell lines, as shown in Table I . Some cell lines contained sialylated and fucosylated nLc 4 Cer-derivatives without precursor nLc 4 Cer, suggesting metabolic potential for the complete conversion of nLc 4 Cer to derivatives. In the case of SKG-II cells, which did not contain fucosylated or sialylated nLc 4 Cer, precursor nLc 4 Cer was found to be accumulated at a significantly high concentration, and this supports the idea that modification of nLc 4 Cer is a major metabolic pathway in human gynecological carcinoma-derived cells. As for Le Y and Le b , they have been proven to be colorectal carcinoma-associated phenotypes useful as markers for diagnosis, [30] [31] [32] [33] and to be synthesized by α1,2-fucosyltransferase from Le X and Le a , respectively. 34) Considering the enzymatic properties of α1,2-fucosyltransferase, which catalyzes the fucosylation of Le X and Le a together, if cancer cells possess the activity, the expression of either Le Y -or Le b -phenotypes should be determined by the supply of the precursor structure, Le X or Le a . Therefore, the best way to detect the transformationassociated alterations in the Lewis-phenotypes would be the simultaneous detection of Le Y and Le b , which could be performed by use of monoclonal antibody MSN-1. As shown in this paper, the MSN-1 antibody was successfully applied to discriminate Lewis-positive cells from negative ones, a distinction that is related to the differentiation types of endometrial adenocarcinomas. HHUA and SNG-II cells preferentially expressed Le Y and Le b , respectively, SNG-M and Ishikawa cells had both structures, and neither structure was expressed in HEC-108 cells, indicating that either Le Y or Le b is expressed in well-and moderately differentiated types of endometrial adenocarcinoma. The results obtained for the cell lines were similar to those for the cancerous tissues, either Le Y or Le b being expressed in the tissues of the well-and moderately differentiated types, but not in the poorly differentiated type. The mode of antigen expression in the cancerous tissues was also in accord with the previous observations using immunohistochemical and flow cytometric procedures with the MSN-1 antibody, whose reactivity was significantly higher in the well-differentiated type than in the poorly differentiated type. 35) From the findings that Lewis-GSLs in endometrial adenocarcinoma-derived cells comprised 0.7 to 3.4% of the total GSLs, and their concentrations were maintained despite the additional sulfating pathway from LacCer to give sulfated GSLs amounting to 7 to 53% of the total GSLs, the synthetic potential for Le Y or Le b was judged to be mainly governed by the supply of the precursor GSLs, resulting in the higher expression of Lewis-phenotypes in the well-differentiated types. Thus, to assess the metabolic background of the expression of tumor-associated Lewis-phenotypes in relation to clinical diagnosis, immunohistochemical detection of antigens, together with analyses of the genes for α1,3/4-and α1,2-fucosyltransferases are essential, and the MSN-1 antibody should provide a powerful tool for probing endometrial adenocarcinoma-associated antigens. 
